HOYA advocates for more public support after ‘generation leap’ in myopia control science
The ARVO meeting last month in Denver was rich in myopia management presentations by lens manufacturers, as has been the case in recent years. However, HOYA Vision Care’s (HOYA) presentation of its latest MiYOSMART iQ clinical trial data drew particular attention, as the company spoke about “halting” myopia in children—while ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.